The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images Postmenopause refers to the time period after the person finishes menopause and no longer has ...
Research suggests that low sexual desire affects 40 per cent of Canadian women and 30 per cent of men. Sexual health is an ...
2d
SynergenX Expands Treatment Options to Give Patients More Flexible Paths to a Better Quality of Life
SynergenX, alongside its affiliated brands Low T Center and HerKare, today announced the launch of an expanded range of ...
Low libido (sex drive) is a decrease in sexual desire. This could mean you have little to no interest in sexual activity. It could also mean you have a hard time getting sexually aroused or having an ...
INDIANAPOLIS (WISH) — This week, the Food and Drug Administration approved Addyi, the first medication for low libido in women younger than 65 years of age. Low libido affects 1 in 8 postmenopausal ...
For decades, sexologists have documented the substantial proportion of women who complain of low libido, known clinically as hypoactive sexual desire disorder (HSDD). Two landmark studies by ...
The U.S. Food and Drug Administration is opening the door to a significant possible expansion in testosterone therapy, signaling that approved drugmakers may now seek authorization to market ...
Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results